MVP and pancreatic adenocarcinoma: Through a comprehensive integration of bioinformatics analysis and experimental investigations, our study unveils that MVP serves not only as a novel biomarker that accelerates the malignant progression of PAAD, but also exerts a noticeable influence on the TME in PAAD.